Clinical trials with human embryonic stem cells possible in 18 months to 3 years

Leading scientists, Pete Coffey and Stephen Minger, respond to questions raised in Parliament on how long it will be before we will see clinical trials with human embryonic stem cells.
For more details see: Embryonic Stem Cell Clinical Trials

The Progess Educational Trust and Natalie Gamble, leading fertility law expert with Lester Aldridge LLP, against the ‘need for a father’ amendments

The PET and Natalie Gamble urge Parliament to reject any amendments to the Bill which would require a ‘need for a father’ clause. They argue that the propsed amendments are inherently discrimminatory towards single women and lesbian couples.
For more on this see: Need for a Father

The British Medical Association supports removal of the ‘need for a father’ clause

The BMA supports the need for fertiliy clinics to consider the welfare of the resultant child, but says that the ‘need for a father clause’ ought to be removed. This would recognise the changes in social attitude which have taken place.
See more here: BMA Briefing Child Welfare and the Need for a Father

Prof Peter Braudie and Dr Ruth Warwick comment on the concept of ’saviour siblings’

Peter braudie and Ruth Warwick, fertility experts, explain the science behind so-called ’saviour siblings’. They provide background information about its use.
See here: Saviour Siblings

British Medical Association supports embryo testing and ’saviour siblings’

The BMA supports the testing of embryos for pre-implantation genetic screening and diagnosis, pre-implantation sex selection for medical reasons, tissue typing, and paternity/maternity testing. They also support the inclusion of a regulatory-making power in the Bill which would enable Parliament to add new types of testing not yet envisaged in the future.
For more information see: [...]

British Medical Association supports for embryo research

The BMA strongly supports the use of human embryos in research subject to statutory controls. They belive that regulation through the HFEA licencing and inspection regime has worked well since 1991 and has helped to maintain public confidence in such research.
For more information see the latest BMA briefing here: BMA Briefing Embryo Research